Microdosing means taking less of a GLP-1 medication than the approved or prescribed dose. It is an off-label practice, and no clinical trial has shown it to be safe or effective for weight loss. A low approved dose chosen by your endocrinologist is different from microdosing. Some patients stay on a low approved dose for months because it suits their response and tolerance. That decision is made and monitored by their endocrinologist.
- Drugs.com describes microdosing Ozempic as an off-label practice with no clinical trials confirming its safety or its effectiveness for weight loss.
- A low approved dose chosen and monitored by your endocrinologist differs from microdosing in who decides on the dose, who monitors it and where the medication comes from.
- Some patients achieve good results at a lower dose, and your maintenance dose is tailored to your individual response and does not necessarily need to be the maximum dose.
- A letter in Diabetes Care in 2025 described clinician-supervised fractional dosing for patients with type 2 diabetes who had significant gastrointestinal side effects, while stating that it remains off-label and untested in trials.
- Splitting doses from a pen can introduce dosing errors, and the pens are not designed to deliver fractions of the labelled dose.
- The US Food and Drug Administration (FDA) states that unapproved and compounded GLP-1 products are not reviewed for safety, effectiveness or quality.
- If side effects are the reason for wanting a smaller dose, your endocrinologist can adjust the pace of dose increases or prescribe medication to help manage them.
The term microdosing is often used for two different practices. One is taking a smaller dose than prescribed without medical supervision. The other is the clinical decision to keep a patient on a low approved dose because it suits their response.
What does microdosing a GLP-1 mean?
Microdosing generally means taking a smaller GLP-1 dose than the approved or prescribed dose. People may attempt this by manipulating pens or using compounded products, which can introduce dosing and safety risks. Drugs.com describes it as an off-label practice that is not approved and has no official guidelines, and notes that reports of appetite suppression at these doses are anecdotal.
The approved doses for Ozempic (semaglutide) start at 0.25 mg once weekly, and for Mounjaro (tirzepatide) at 2.5 mg once weekly. Our Mounjaro dose ladder page sets out the approved doses. Microdosing usually refers to a dose below the lowest of these.
Is microdosing approved or studied?
Microdosing is neither approved nor studied as a treatment for weight loss. No clinical trial has evaluated microdosing for weight loss, so there is no evidence on how much weight patients lose, how long any effect lasts or what the long-term safety is. The prescribing information for each product describes only the approved doses.
A letter in Diabetes Care in 2025 from clinicians at the University of North Carolina described supervised fractional dosing with multi-dose semaglutide pens for patients with type 2 diabetes who had significant gastrointestinal side effects. The authors state that the practice is off-label, that no clinical trials have validated its safety or efficacy, and that it needs careful patient selection and close monitoring by a clinician. The practice described in the letter is led and monitored by a doctor.
Can you lose weight on a very low dose?
Some patients may, although no trial has measured how many. The response to a GLP-1 medication is individual. Some patients start to see weight changes from around week two, while others take longer to respond. The prescribing information describes the starting doses of Ozempic and Mounjaro as intended for treatment initiation, and the clinical trials measured their weight loss results at the maintenance doses.
Feeling less hungry at a fraction of a dose is a real experience. It does not show that the fraction is the right dose. Regular monitoring of weight and body composition shows whether a dose is helping.
When is a low dose legitimate clinical practice?
Patients who cannot tolerate a step up
Side effects such as nausea or constipation can be particularly pronounced in the first few days at a new dose and usually settle within the first two weeks at that step. Where side effects persist, your endocrinologist can hold you at the current dose for longer, slow the pace of dose increases and, where needed, prescribe medication to help manage these side effects. Some patients stay at a low dose for several months, and this is a clinical decision made at your follow-up.
Patients settling on a maintenance dose
A maintenance dose is the dose that helps maintain your results once you have reached your target weight and achieved the symptom control you were treated for. The dose is reviewed with your endocrinologist at each monthly follow-up. Some patients achieve good results at a lower dose, while others gradually increase to a higher dose. Your maintenance dose is tailored to your individual response and does not necessarily need to be the maximum dose. Our article on the maintenance dose explains how that dose is chosen.
What separates these two situations from microdosing is who decides on the dose, who monitors it, where the medication comes from and whether the pen is designed to deliver that dose.
What are the risks of microdosing without a doctor?
Unlicensed and compounded supply
Microdosing can also involve buying compounded or unlicensed products online. The US Food and Drug Administration (FDA) states that unapproved GLP-1 products, including compounded semaglutide and tirzepatide, are not reviewed for safety, effectiveness or quality, and it has received reports of dosing errors with compounded injectable semaglutide. Our article on compounded semaglutide and tirzepatide explains what those products are.
Splitting doses from a pen
Pens deliver the labelled doses and are not designed to deliver fractions of them. Attempting to take part of a dose from a pen can introduce dosing errors in both directions. The manufacturer of Ozempic discourages attempts to measure partial doses from the pen.
Some patients split a pen to reduce cost. In the UAE, the medication price for Mounjaro is AED 1,734 per month, the same at every dose from 2.5 mg to 15 mg. Endocare adds no markup to the official pharmacy price and does not earn on medication. Patients for whom cost is a concern can discuss the treatment options with their endocrinologist at the consultation.
Why do some people feel better on a low dose?
Side effects such as nausea and constipation are dose-related for many patients, so a lower dose can mean fewer side effects alongside less effect on appetite. Those experiences are real. They do not show that the low dose is enough to treat the condition for which a doctor prescribed the medication. Your endocrinologist can assess whether a lower dose is appropriate for you and monitor what it does to your weight and your body composition.
How does Endocare decide your dose?
Dose decisions are made by your endocrinologist together with you at the monthly follow-up, in roughly four-week increments, based on your weight loss response, how well you tolerate the medication and your body composition trends. There is no automatic increase after four weeks. Some patients stay at 2.5 mg of Mounjaro, or at a low dose of Wegovy or Ozempic, for several months with good results, while others need to increase to a higher dose for the best response.
At Endocare, body composition analysis is included free of charge at every consultation. Body composition analysis estimates body fat, muscle mass and body water. Repeated measurements help your endocrinologist understand how your body is changing beyond the number on the scale. The analysis is part of the dose decision. Patients should not decide by themselves to start a GLP-1 medication. A doctor’s review is critical to ensure the treatment is safe and appropriate for the individual.
Frequently asked questions
Is microdosing Ozempic safe?
Its safety has not been shown. No clinical trial has evaluated microdosing for weight loss, and the practice can involve splitting pens or buying compounded products, both of which carry risks that the licensed dose does not. A low approved dose prescribed and monitored by your endocrinologist is a separate clinical decision.
Can you lose weight on 0.25 mg of Ozempic?
Some patients do notice reduced appetite and some weight change at the starting dose, and the response is individual. The prescribing information describes the 0.25 mg dose as intended for treatment initiation, and the clinical trials measured weight loss at the maintenance doses. Your endocrinologist will review your response at each monthly follow-up.
Is a low maintenance dose the same as microdosing?
A low maintenance dose is not the same as microdosing. A maintenance dose is an approved dose chosen by your endocrinologist from your response and tolerance, delivered by the pen as designed, and reviewed at each follow-up. Microdosing is a dose below the approved range, taken without that supervision.
Can I split a dose from my pen?
We do not recommend splitting a dose. Pens are designed to deliver the labelled doses, and attempting to take part of a dose can introduce dosing errors. The manufacturer of Ozempic discourages the practice. If the dose you are prescribed is causing side effects, raise it at your next follow-up.
Does microdosing reduce side effects?
A lower dose can mean fewer side effects for many patients, which is why your endocrinologist can slow the pace of dose increases or hold a dose for longer. Side effects can be particularly pronounced in the first few days at a new dose and usually settle within the first two weeks, and your endocrinologist can prescribe medication to help manage them where needed.
Why do some people feel better on a low dose?
Fewer side effects and a milder effect on appetite are often the reasons. Those experiences are real. They do not show that the low dose is enough to treat the condition, and your endocrinologist will review the dose at each follow-up.
If you are taking less than your prescribed dose, or considering it, we recommend raising it at your next follow-up. Your endocrinologist can review your side effects, your response and your body composition analysis, and can hold, lower or slow the dose where that is appropriate for you.
You can talk to an endocrinologist at our clinics in Dubai and Abu Dhabi.
